|
1
|
McLaughlin CC, Wu XC, Jemal A, Martin HJ,
Roche LM and Chen VW: Incidence of noncutaneous melanomas in the
U.S. Cancer. 103:1000–1007. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Shields CL, Furuta M, Thangappan A, Nagori
S, Mashayekhi A, Lally DR, Kelly CC, Rudich DS, Nagori AV, Wakade
OA, et al: Metastasis of uveal melanoma millimeter-by-millimeter in
8033 consecutive eyes. Arch Ophthalmol. 127:989–998. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Damato B: Ocular treatment of choroidal
melanoma in relation to the prevention of metastatic death-A
personal view. Prog Retin Eye Res. 66:187–199. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Damato B, Eleuteri A, Azzam FGT and
Coupland SE: Estimating prognosis for survival after treatment of
choroidal melanoma. Prog Retina Eye Res. 30:285–295. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Sun S, Shi R, Xu L and Sun F:
Identification of heterogeneity and prognostic key genes associated
with uveal melanoma using single-cell RNA-sequencing technology.
Melanoma Res. 32:18–26. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Eskelin S, Pyrhönen S, Summanen P,
Hahka-Kemppinen M and Kivel T: Tumor doubling times in metastatic
malignant melanoma of the uvea: Tumor progression before and after
treatment. Ophthalmology. 107:1443–1449. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Hou C, Xiao L, Ren X, Tang F, Guo B, Zeng
W, Liang C and Yan N: Mutations of GNAQ, GNA11, SF3B1, EIF1AX,
PLCB4 and CYSLTR in uveal melanoma in Chinese patients. Ophthalmic
Res. 63:358–368. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Robertson AG, Shih J, Yau C, Gibb EA, Oba
J, Mungall KL, Hess JM, Uzunangelov V, Walter V, Danilova L, et al:
Integrative analysis identifies four molecular and clinical subsets
in uveal melanoma. Cancer Cell. 32:204–220. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Gupta MP, Lane AM, Deangelis MM, Mayne K,
Crabtree M, Gragoudas ES and Kim IK: Clinical characteristics of
uveal melanoma in patients with germline BAP1 mutations. JAMA
Ophthalmol. 133:881–887. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Jager MJ, Ly LV, El Filali M and Madigan
MC: Macrophages in uveal melanoma and in experimental ocular tumor
models: Friends or foes? Prog Retin Eye Res. 30:129–146. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Rossi E, Schinzari G, Zizzari IG, Maiorano
BA, Pagliara MM, Sammarco MG, Fiorentino V, Petrone G, Cassano A,
Rindi G, et al: Immunological backbone of uveal melanoma: Is there
a rationale for immunotherapy? Cancers (Basel). 11:10552019.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhang Y, Wang D, Peng M, Tang L, Ouyang J,
Xiong F, Guo C, Tang Y, Zhou Y, Liao Q, et al: Single-cell RNA
sequencing in cancer research. J Exp Clin Cancer Res. 40:812021.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Pandiani C, Strub T, Nottet N, Cheli Y,
Gambi G, Bille K, Husser C, Dalmasso M, Béranger G, Lassalle S, et
al: Single-cell RNA sequencing reveals intratumoral heterogeneity
in primary uveal melanomas and identifies HES6 as a driver of the
metastatic disease. Cell Death Differ. 28:1990–2000. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Durante MA, Rodriguez DA, Kurtenbach S,
Kuznetsov JN, Sanchez MI, Decatur CL, Snyder H, Feun LG,
Livingstone AS and Harbour JW: Single-cell analysis reveals new
evolutionary complexity in uveal melanoma. Nat Commun. 11:4962020.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Schwager SC, Taufalele PV and
Reinhart-King CA: Cell-cell mechanical communication in cancer.
Cell Mol Bioeng. 12:1–14. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Bai H, Bosch JJ and Heindl LM: Current
management of uveal melanoma: A review. Clin Exp Ophthalmol.
51:484–494. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kaštelan S, Antunica AG, Oresković LB,
Pelčić G, Kasun E and Hat K: Immunotherapy for uveal
melanoma-Current knowledge and perspectives. Curr Med Chem.
27:1350–1366. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Oliva M, Rullan AJ and Piulats JM: Uveal
melanoma as a target for immune-therapy. Ann Transl Med. 4:1722016.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Tomczak K, Czerwińska P and Wiznerowicz M:
The cancer genome atlas (TCGA): An immeasurable source of
knowledge. Contemp Oncol (Pozn). 19:A68–A77. 2015.PubMed/NCBI
|
|
20
|
Weinstein JN, Collisson EA, Mills GB, Shaw
KR, Ozenberger BA, Ellrott K, Shmulevich I, Sander C and Stuart JM;
Cancer Genome Atlas Research Network, : The cancer genome atlas
pan-cancer analysis project. Nat Genet. 45:1113–1120. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Davis S and Meltzer PS: GEOquery: A bridge
between the gene expression omnibus (GEO) and bioconductor.
Bioinformatics. 23:1846–1847. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Hao Y, Hao S, Andersen-Nissen E, Mauck WM
III, Zheng S, Butler MJ, Lee A, Wilk AJ, Darby C, Zager M, et al:
Integrated analysis of multimodal single-cell data. Cell.
184:3573–3587.e29. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Garcia-Alonso L, Lorenzi V, Mazzeo CI,
Alves-Lopes JP, Roberts K, Sancho-Serra C, Engelbert J, Marečková
M, Gruhn WH, Botting RA, et al: Single-cell roadmap of human
gonadal development. Nature. 607:540–547. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Efremova M, Vento-Tormo M, Teichmann SA
and Vento-Tormo R: CellPhoneDB: Inferring cell-cell communication
from combined expression of multi-subunit ligand-receptor
complexes. Nat Protoc. 15:1484–1506. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Yu G, Wang LG, Han Y and He QY:
ClusterProfiler: An R package for comparing biological themes among
gene clusters. OMICS. 16:284–287. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Shannon P, Markiel A, Ozier O, Baliga NS,
Wang JT, Ramage D, Amin N, Schwikowski B and Ideker T: Cytoscape: A
software environment for integrated models of biomolecular
interaction networks. Genome Res. 13:2498–2504. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ishwaran H, Kogalur UB, Blackstone EH and
Lauer MS: Random survival forests. 2008. View Article : Google Scholar
|
|
28
|
Newman AM, Steen CB, Liu CL, Gentles AJ,
Chaudhuri AA, Scherer F, Khodadoust MS, Esfahani MS, Luca BA,
Steiner D, et al: Determining cell type abundance and expression
from bulk tissues with digital cytometry. Nat Biotechnol.
37:773–782. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Li H, Han D, Hou Y, Chen H and Chen Z:
Statistical inference methods for two crossing survival curves: A
comparison of methods. PLoS One. 10:e01167742015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Neophytou CM, Panagi M, Stylianopoulos T
and Papageorgis P: The role of tumor microenvironment in cancer
metastasis: Molecular mechanisms and therapeutic opportunities.
Cancers (Basel). 13:20532021. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
García-Mulero S, Alonso MH, Del Carpio LP,
Sanz-Pamplona R and Piulats JM: Additive role of immune system
infiltration and angiogenesis in uveal melanoma progression. Int J
Mol Sci. 22:26692021. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Voigt AP, Mullin NK, Stone EM, Tucker BA,
Scheetz TE and Mullins RF: Single-cell RNA sequencing in vision
research: Insights into human retinal health and disease. Prog
Retin Eye Res. 83:1009342021. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Castet F, Garcia-Mulero S, Sanz-Pamplona
R, Cuellar A, Casanovas O, Caminal JM and Piulats JM: Uveal
melanoma, angiogenesis and immunotherapy, is there any hope?
Cancers (Basel). 11:8342019. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Notting IC, Missotten GS, Sijmons B,
Boonman ZF, Keunen JE and van der Pluijm G: Angiogenic profile of
uveal melanoma. Curr Eye Res. 31:775–785. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Potente M and Mäkinen T: Vascular
heterogeneity and specialization in development and disease. Nat
Rev Mol Cell Biol. 18:477–494. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Hanahan D and Weinberg RA: Hallmarks of
cancer: The next generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Krüger-Genge A, Blocki A, Franke RP and
Jung F: Vascular endothelial cell biology: An update. Int J Mol
Sci. 20:44112019. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Thiery JP, Acloque H, Huang RY and Nieto
MA: Epithelial-mesenchymal transitions in development and disease.
Cell. 139:871–890. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Nieto MA: The ins and outs of the
epithelial to mesenchymal transition in health and disease. Annu
Rev Cell Dev Biol. 27:347–376. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Kimura C, Hayashi M, Mizuno Y and Oike M:
Endothelium-dependent epithelial-mesenchymal transition of tumor
cells: Exclusive roles of transforming growth factor β1 and β2.
Biochim Biophys Acta. 1830:4470–4481. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Shenoy AK and Lu J: Cancer cells remodel
themselves and vasculature to overcome the endothelial barrier.
Cancer Lett. 380:534–544. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Sonbul SN, Aleskandarany MA, Kurozumi S,
Joseph C, Toss MS, Diez-Rodriguez M, Diez-Rodriguez M, Nolan CC,
Mukherjee A, Martin S, et al: Saccharomyces cerevisiae-like 1
(SEC14L1) is a prognostic factor in breast cancer associated with
lymphovascular invasion. Mod Pathol. 31:1675–1682. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Agell L, Hernández S, Nonell L, Lorenzo M,
Puigdecanet E, de Muga S, Juanpere N, Bermudo R, Fernández PL,
Lorente JA, et al: A 12-gene expression signature is associated
with aggressive histological in prostate cancer: SEC14L1 and TCEB1
genes are potential markers of progression. Am J Pathol.
181:1585–1594. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Guo Q, Zhao L, Yan N, Li Y, Guo C, Dang S,
Shen X, Han J and Luo Y: Integrated pan-cancer analysis and
experimental verification of the roles of tropomyosin 4 in gastric
cancer. Front Immunol. 14:11480562023. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Lu J, Li XP, Dong Q, Kung HF and He ML:
TBX2 and TBX3: The special value for anticancer drug targets.
Biochim Biophys Acta. 1806:268–274. 2010.PubMed/NCBI
|
|
47
|
Fatemi Langroudi SR, Zeinaly M and Ajamian
F: TBX21, the Master regulator of the type 1 immune response,
overexpresses in the leukocytes of peripheral blood in patients
with late-onset Alzheimer's disease. Immun Ageing. 20:592023.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Hagihara K, Haraguchi N, Nishimura J,
Yasueda A, Fujino S, Ogino T, Takahashi H, Miyoshi N, Uemura M,
Matsuda C, et al: PLXND1/SEMA3E promotes epithelial-mesenchymal
transition partly via the PI3k/AKT-signaling pathway and induces
heterogenity in colorectal cancer. Ann Surg Oncol. 29:7435–7445.
2022. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Jurcak NR, Rucki AA, Muth S, Thompson E,
Sharma R, Ding D, Zhu Q, Eshleman JR, Anders RA, Jaffeeet EM, et
al: Axon guidance molecules promote perineural invasion and
metastasis of orthotopic pancreatic tumors in mice.
Gastroenterology. 157:838–850.e6. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Sun M, Chen Z, Song Y, Zhang B, Yang J and
Tan H: PLXND1-mediated calcium dyshomeostasis impairs endocardial
endothelial autophagy in atrial fibrillation. Front Physiol.
13:9604802022. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Mehta V, Pang KL, Rozbesky D, Nather K,
Keen A, Lachowski D, Kong Y, Karia D, Ameismeier M, Huang J, et al:
The guidance receptor plexin D1 is a mechanosensor in endothelial
cells. Nature. 578:290–295. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Silva-Rodríguez P, Fernández-Díaz D, Bande
M, Pardo M, Loidi L and Blanco-Teijeiro MJ: GNAQ and
GNA11 Genes: A Comprehensive review on oncogenesis,
prognosis and therapeutic opportunities in uveal melanoma. Cancers
(Basel). 14:30662022. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Gilman AG: G proteins: Transducers of
receptor-generated signals. Annu Rev Biochem. 56:615–649. 1987.
View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Rodbell M: Nobel Lecture. Signal
transduction: Evolution of an idea. Biosci Rep. 15:117–133. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Ha JH, Jayaraman M, Yan M, Dhanasekaran P,
Isidoro C, Song YS and Dhanasekaran DN: GNAi2/gip2-regulated
transcriptome and its therapeutic significance in ovarian cancer.
Biomolecules. 11:12112021. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Raymond JR Jr, Appleton KM, Pierce JY and
Peterson YK: Suppression of GNAI2 message in ovarian cancer. J
Ovarian Res. 7:62014. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Lapitz A, Azkargorta M, Milkiewicz P,
Olaizola P, Zhuravleva E, Grimsrud MM, Schramm C, Arbelaiz A,
O'Rourke CJ, Casta AL, et al: Liquid biopsy-based protein
biomarkers for risk prediction, early diagnosis, and
prognostication of cholangiocarcinoma. J Hepatol. 79:93–108. 2023.
View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Polak ME, Borthwick NJ, Johnson P,
Hungerford JL, Higgins B, Di Palma S, JagerM J and Cree IA:
Presence and phenotype of dendritic cells in uveal melanoma. Br J
Ophthalmol. 91:971–976. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
de Waard-Siebinga I, Hilders CG, Hansen
BE, van Delft JL and Jager MJ: HLA expression and
tumor-infiltrating immune cells in uveal melanoma. Graefes Arch
Clin Exp Ophthalmol. 234:34–42. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Wang W, Zhao H and Wang S: Identification
of a novel immune-related gene signature for prognosis and the
tumor microenvironment in patients with uveal melanoma combining
single-cell and bulk sequencing data. Front Immunol.
14:10990712023. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Seth R, Messersmith H, Kaur V, Kirkwood
JM, Kudchadkar R, McQuade JL, Provenzano A, Swami U, Weber J,
Alluri KC, et al: Systemic therapy for melanoma: ASCO Guideline. J
Clin Oncol. 38:3947–3970. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Qi Y, Cui Q, Zhang W, Yao R, Xu D and
Zhang F: Long non-coding RNA GAS5 targeting microRNA-21 to suppress
the invasion and epithelial-mesenchymal transition of uveal
melanoma. Cancer Manag Res. 12:12259–12267. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Tay Y, Rinn J and Pandolfi PP: The
multilayered complexity of ceRNA crosstalk and competition. Nature.
505:344–352. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Barbagallo C, Di Maria A, Alecci A,
Barbagallo D, Alaimo S, Colarossi L, Ferro A, Di Pietro C, Purrello
M, Pulvirenti A and Ragusa M: VECTOR: An integrated correlation
network database for the identification of CeRNA axes in uveal
melanoma. Genes (Basel). 12:10042021. View Article : Google Scholar : PubMed/NCBI
|
